BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 6315087)

  • 1. [The process of cyclic adenosine-3',5'-monophosphate phosphodiesterase activation by 2',5'-oligoadenylate].
    Tunitskaia VL; Itkes AV; Kochetkova MN; Severin ES
    Biokhimiia; 1983 Oct; 48(10):1721-5. PubMed ID: 6315087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Kinetic properties and regulation of cyclic nucleotide phosphodiesterases in lymphoid cells].
    Azhaeva EV; Severin ES
    Bioorg Khim; 1987 Sep; 13(9):1157-63. PubMed ID: 2827690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aggregation states of cyclic nucleotide phosphodiesterase of murine thymocytes.
    Sobolev AS; Rybalkin SD
    Cell Biochem Funct; 1986 Jul; 4(3):205-11. PubMed ID: 3015450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations in cyclic AMP phosphodiesterase activities during differentiation of 3T3-L1 cells.
    Manganiello VC; Reed BC; Lieberman FS; Moss J; Lane MD; Vaughan M
    J Cyclic Nucleotide Protein Phosphor Res; 1983; 9(2):143-54. PubMed ID: 6196386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A study on the relationship between the interferon enzyme system and the system of cyclic nucleotide metabolism.
    Kafiani CA; Itkes AV; Kartasheva ON; Kochetkova MN; Turpaev KT; Severin ES
    Adv Enzyme Regul; 1983; 21():353-65. PubMed ID: 6085824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclic nucleotide phosphodiesterase activity in patients with obstructive airways disease.
    Polson JB; Krzanowski JJ; Goldman AL; Szentivanyi A
    Allergol Immunopathol (Madr); 1982; 10(2):101-4. PubMed ID: 6125092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of rat thymocyte proliferative response through the inhibition of different cyclic nucleotide phosphodiesterase isoforms by means of selective inhibitors and cGMP-elevating agents.
    Marcoz P; Prigent AF; Lagarde M; Nemoz G
    Mol Pharmacol; 1993 Nov; 44(5):1027-35. PubMed ID: 8246905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclic nucleotide derivatives as probes of phosphodiesterase catalytic and regulatory sites.
    Erneux C; Couchie D; Dumont JE; Jastorff B
    Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984; 16():107-18. PubMed ID: 6326517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of a human melanoma cell line (KHm-1) containing phosphodiesterase activity only for cyclic adenosine 3':5'-monophosphate.
    King LE; Solomon SS; Hashimoto K
    Cancer Res; 1978 Nov; 38(11 Pt 1):3879-85. PubMed ID: 29705
    [No Abstract]   [Full Text] [Related]  

  • 10. Control of platelet activation by cyclic AMP turnover and cyclic nucleotide phosphodiesterase type-3.
    Feijge MA; Ansink K; Vanschoonbeek K; Heemskerk JW
    Biochem Pharmacol; 2004 Apr; 67(8):1559-67. PubMed ID: 15041473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Multiple forms of cyclic nucleotide phosphotransferases in mouse thymocytes].
    Rybalkin SD; Kurennaia GS; Sobolev AS
    Biokhimiia; 1984 Dec; 49(12):1927-33. PubMed ID: 6098315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Properties of cyclic nucleotide phosphodiesterase from lingual taste papillae].
    Ostretsova IB
    Biokhimiia; 1978 Jun; 43(6):1037-44. PubMed ID: 27246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Changes in the ratio of cyclic nucleotide phosphodiesterase forms in the thymocytes of irradiated mice].
    Rybalkin SD; Sobolev AS
    Radiobiologiia; 1986; 26(2):167-70. PubMed ID: 3010370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of human lymphocyte high affinity cyclic AMP phosphodiesterase by culture with 1-methyl-3-isobutylxanthine.
    Thompson WJ; Ross CP; Hersh EM; Epstein PM; Strada SJ
    J Cyclic Nucleotide Res; 1980; 6(1):25-36. PubMed ID: 6155390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cyclic AMP-specific nucleotide phosphodiesterase from the insoluble fraction of the human brain].
    Kireeva NN; Bobruskin ID; Severin SE
    Biokhimiia; 1995 May; 60(5):694-708. PubMed ID: 7662796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of a cAMP/cGMP phosphodiesterase sensitive to calmodulin [proceedings].
    Ilien B; Landry Y
    Arch Int Physiol Biochim; 1980 Feb; 88(1):B32-B33. PubMed ID: 6155846
    [No Abstract]   [Full Text] [Related]  

  • 17. Regulation of cyclic nucleotide phosphodiesterase forms by serum and insulin in cultured fibroblasts.
    Pledger WJ; Thompson WJ; Epstein PM; Strada SJ
    J Cell Physiol; 1979 Sep; 100(3):497-507. PubMed ID: 226555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of rat cerebral cortical 3',5'-cyclic nucleotide phosphodiesterase activity by gangliosides.
    Davis CW; Daly JW
    Mol Pharmacol; 1980 Mar; 17(2):206-11. PubMed ID: 6248757
    [No Abstract]   [Full Text] [Related]  

  • 19. A simple direct assay of 3',5'-cyclic nucleotide phosphodiesterase activity based on the use of polyacrylamide-bononate affinity gel chromatography.
    Davis CW; Daly JW
    J Cyclic Nucleotide Res; 1979; 5(1):65-74. PubMed ID: 220290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased cyclic nucleotide phosphodiesterase activity associated with proliferation and cancer in human and murine lymphoid cells.
    Epstein PM; Mills JS; Ross CP; Strada SJ; Hersh EM; Thompson WJ
    Cancer Res; 1977 Nov; 37(11):4016-23. PubMed ID: 198126
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.